Cancerimmunotherapy is one of the most promising research areasin the field of cancer therapy.Along the lO drug development process, production of mouse models forin vivo efficacy evaluation has always been a rate-limiting step. Therefore, We generated a novel humanized knock-in mouse toevaluate the efficacy of human lO antibodies.
